New program helps latino cancer patients voice their care wishes
NCT ID NCT04889144
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tested a program called PLAN to help Latino cancer patients plan for their future medical care. Twenty-seven patients with advanced cancer took part. The program aimed to improve their understanding and communication about advance care planning with doctors and family. Researchers measured how helpful and feasible the program was.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Planning for Your Advance Care Needs (PLAN) intervention
What this could lead to
If successful, this program could help Latino cancer patients better understand and communicate their care wishes, leading to more personalized end-of-life care.
What could go wrong
This was a small, early feasibility study with only 27 participants. Results may not apply to all Latino patients, and the program may not improve actual care outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC MALIGNANT SOLID NEOPLASM are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Confluence Health
Wenatchee, Washington, 98801, United States
-
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, 98109, United States
-
UT Southwestern/Simmons Cancer Center-Dallas
Dallas, Texas, 75390, United States
-
Weill Cornell Medicine
New York, New York, 10021, United States